Akebia Therapeutics Inc (AKBA)

CapEx to Revenue

2.20%

Quarterly · Period ending:

AKBA logo

AKBA CapEx to Revenue

Latest reported2.20%
AKBA Quarterly CapEx/Revenue (0.00% → 2.20%)
High-resolution chart · PNG

AKBA capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Akebia Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
2.1963%
0.1158%
0.2812%
0.131%
0.2017%
0.0314%
0.0043%
0.0053%
0.0664%
0%
0%
0%
0%
0%
0%
0%
0%
0.1848%
0%
0%
0%
0.1128%
0.5591%
0.075%
0.0499%
0%
0.3163%
2.7496%
1.9622%
2.6532%
1.3868%
0.5774%
0.3546%
0.6445%
0.5154%
1.4461%
0.5189%
2.0465%
3.127%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.